Article Versions Notes

Karampitsakos T, Galaris A, Barbayianni I, DeIuliis G, Ahangari F, Sampsonas F, Sotiropoulou V, Aidinis V, Bennett AM, Herazo-Maya JD, et al. SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts. Diagnostics. 2023; 13(6):1166. https://doi.org/10.3390/diagnostics13061166

Karampitsakos, Theodoros, Apostolos Galaris, Ilianna Barbayianni, Giuseppe DeIuliis, Farida Ahangari, Fotis Sampsonas, Vasilina Sotiropoulou, Vassilis Aidinis, Anton M. Bennett, Jose D. Herazo-Maya, and et al. 2023. "SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts" Diagnostics 13, no. 6: 1166. https://doi.org/10.3390/diagnostics13061166

Karampitsakos, T., Galaris, A., Barbayianni, I., DeIuliis, G., Ahangari, F., Sampsonas, F., Sotiropoulou, V., Aidinis, V., Bennett, A. M., Herazo-Maya, J. D., Xylourgidis, N., Bakakos, P., Bouros, D., Kaminski, N., & Tzouvelekis, A. (2023). SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts. Diagnostics, 13(6), 1166. https://doi.org/10.3390/diagnostics13061166